Literature DB >> 17922017

In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit.

José Luis Royo1, Pablo Daniel Becker, Eva María Camacho, Angel Cebolla, Claudia Link, Eduardo Santero, Carlos Alberto Guzmán.   

Abstract

Systems allowing tightly regulated expression of prokaryotic genes in vivo are important for performing functional studies of bacterial genes in host-pathogen interactions and establishing bacteria-based therapies. We integrated a regulatory control circuit activated by acetyl salicylic acid (ASA) in attenuated Salmonella enterica that carries an expression module with a gene of interest under control of the XylS2-dependent Pm promoter. This resulted in 20-150-fold induction ex vivo. The regulatory circuit was also efficiently induced by ASA when the bacteria resided in eukaryotic cells, both in vitro and in vivo. To validate the circuit, we administered Salmonella spp., carrying an expression module encoding the 5-fluorocytosine-converting enzyme cytosine deaminase in the bacterial chromosome or in a plasmid, to mice with tumors. Induction with ASA before 5-fluorocytosine administration resulted in a significant reduction of tumor growth. These results demonstrate the usefulness of the regulatory control circuit to selectively switch on gene expression during bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922017     DOI: 10.1038/nmeth1107

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  27 in total

1.  Advances in bacterial cancer therapies using synthetic biology.

Authors:  Tiffany Chien; Anjali Doshi; Tal Danino
Journal:  Curr Opin Syst Biol       Date:  2017-05-23

Review 2.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

Review 3.  Salmonella-allies in the fight against cancer.

Authors:  Sara Leschner; Siegfried Weiss
Journal:  J Mol Med (Berl)       Date:  2010-06-05       Impact factor: 4.599

Review 4.  Engineering bacteria for diagnostic and therapeutic applications.

Authors:  David T Riglar; Pamela A Silver
Journal:  Nat Rev Microbiol       Date:  2018-02-05       Impact factor: 60.633

Review 5.  Exploitation of prokaryotic expression systems based on the salicylate-dependent control circuit encompassing nahR/P(sal)::xylS2 for biotechnological applications.

Authors:  Pablo D Becker; Jose L Royo; Carlos A Guzman
Journal:  Bioeng Bugs       Date:  2010-01-12

6.  Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice.

Authors:  Jochen Stritzker; Philip J Hill; Ivaylo Gentschev; Aladar A Szalay
Journal:  Bioeng Bugs       Date:  2009-10-09

7.  Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strains.

Authors:  Jochen Stritzker; Sascha Huppertz; Qian Zhang; Ulrike Geissinger; Barbara Härtl; Ivaylo Gentschev; Aladar A Szalay
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

Review 8.  Engineering the gut microbiota to treat chronic diseases.

Authors:  Noura S Dosoky; Linda S May-Zhang; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2020-07-21       Impact factor: 4.813

9.  Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.

Authors:  Sheng-Nan Jiang; Seung-Hwan Park; Hee Jung Lee; Jin Hai Zheng; Hyung-Seok Kim; Hee-Seung Bom; Yeongjin Hong; Michael Szardenings; Myung Geun Shin; Sun-Chang Kim; Vasilis Ntziachristos; Hyon E Choy; Jung-Joon Min
Journal:  Mol Ther       Date:  2013-08-07       Impact factor: 11.454

10.  Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors.

Authors:  Adam T St Jean; Charles A Swofford; Jan T Panteli; Zachary J Brentzel; Neil S Forbes
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.